Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hung-Fang Pan"'
Autor:
Chiou-Mei Wu, Po-Ju Wei, Yu-Ting Shen, Hsu-Liang Chang, Ying-Ming Tsai, Hung-Fang Pan, Yong-Chieh Chang, Yu-Ching Wei, Chih-Jen Yang
Publikováno v:
Antibiotics, Vol 8, Iss 3, p 134 (2019)
Gemifloxacin is a common oral antibiotic for lower respiratory tract infection worldwide. We noticed an uncommon delayed onset skin rash in patients who received Gemifloxacin. Therefore, we retrospectively reviewed all patients who received Gemifloxa
Externí odkaz:
https://doaj.org/article/c27f88b94be342a78f172a743b467de4
Autor:
Hung-Fang Pan, 潘虹方
103
Background: Previous case reports revealed that concomitant therapy with calcium channel blockers and macrolides resulted in hypotension. In 2012, the U.S. FDA issued a warning to remind physicians that the combination of clarithromycin and
Background: Previous case reports revealed that concomitant therapy with calcium channel blockers and macrolides resulted in hypotension. In 2012, the U.S. FDA issued a warning to remind physicians that the combination of clarithromycin and
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/44812119808367474872
Autor:
Yong-Chieh Chang, Ya-Ling Wang, Tun-Chieh Chen, Yung-Shun Juan, Hung-Fang Pan, Wei-Hsuan Huang, Hsiao-Ling Chen, Chiou-Mei Wu, Hsiu-Mei Chang, Hsiang-Ying Lee
Publikováno v:
World journal of urology. 36(8)
Mirabegron, a β3-adrenoceptor agonist, was approved for overactive bladder (OAB), but worsened hypertension was a potential risk based on its mechanism of action. Besides, head to head comparisons were limited between mirabegron and antimuscarinic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d9d14f389e5073a726257f52facd6f8
https://pubmed.ncbi.nlm.nih.gov/29556972
https://pubmed.ncbi.nlm.nih.gov/29556972
Autor:
Hung-Fang Pan, Yong-Chieh Chang, Yu-Ting Shen, Po-Ju Wei, Hsu-Liang Chang, Chih-Jen Yang, Yu-Ching Wei, Chiou-Mei Wu, Ying-Ming Tsai
Publikováno v:
Antibiotics
Volume 8
Issue 3
Antibiotics, Vol 8, Iss 3, p 134 (2019)
Volume 8
Issue 3
Antibiotics, Vol 8, Iss 3, p 134 (2019)
Gemifloxacin is a common oral antibiotic for lower respiratory tract infection worldwide. We noticed an uncommon delayed onset skin rash in patients who received Gemifloxacin. Therefore, we retrospectively reviewed all patients who received Gemifloxa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3436f00a2495bc73a4f9eb669949799
https://doi.org/10.3390/antibiotics8030134
https://doi.org/10.3390/antibiotics8030134